SENISCA
Higher Education · Brewing & Beer
$4.7Mlatest round · Venture round · Mar 2024 · 2 yr ago
1backers · APEX Ventures
10+team · employees, estimated range
19stories in the press
Overview
Forward thinking to reverse cell ageing. SENISCA targets the process of cellular ageing (senescence) via the development of RNA senotherapeutics which specifically target the causative molecular mechanisms that drive senescence.
Key facts
These are the key facts about SENISCA on Alion as of Nov 13, 2026. The latest round is Venture - Series Unknown of $4.7M, announced in 2024.
- Employees
- 10+Alion company profile, an estimated range
- Total raised
- $4.7MSum of 1 equity round Alion knows
- Latest round
- Venture - Series Unknown · $4.7M · Mar 18, 2024Press report · menafn.com
Funding and backers
Total raised
$4.7M
1 round on record
Latest round
$4.7M
Venture round · Mar 2024 · 2 yr ago
Team
11-50
employees, estimated range
Backers
1
APEX Ventures
The money's age
Long since its last round
31 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 9, 2024
Board appointment SENISCA appoints Tim Edwards as Chair of the Board · streetinsider.com
Mar 18, 2024
Raised a round Venture round $4.7M · menafn
Aug 2020
Website went live first capture in the Wayback Machine
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Mar 2024 | $4.7M | — | menafn |
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Fiber Elements offers technology for the fully automated production of basalt fiber reinforcement structures.
Pincelli is a pre-clinical stage biotech company focused on the development of innovative first-in-class treatments for rare skin diseases.
Promising and Ultimate RNA Medicine. Aiming innovative nucleic acid drugs that cure patients.
For Youth was built to help people stay strong, sharp, and unstoppable—no matter their age. Backed by NUS researchers, we created a…
TURN YOUR DAILY EXPERIENCES INTO LIFE-LONG SKILLS. Send us a message.
Bioprocess & Bioinformatics Insights. Transforming complex omics and bioprocess data into insights your whole team can act on, no coding…
Financials
Total raised
$4.7M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2024 | $4.7M | Details |
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
APEX VenturesVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Shared investors
News
LifeSpan Vision Ventures Invests in SENISCA
/PRNewswire/ -- LifeSpan Vision Ventures, an investment firm specializing in longevity biotech investments, today announced an investment in SENISCA, an RNA...
Read more
Report
SENISCA secures additional £3.7 million financing to support rapid development of senotherapeutic platform to treat age-related disease
SENISCA secures additional £3.7 million financing to support rapid development of senotherapeutic platform to treat age-related disease £3.7 million seed financing supported by consortium of new and existing investors will fund continued preclinical devel
Read more
Report
SENISCA Secures Additional £3.7 Million Financing To Support Rapid Development Of Senotherapeutic Platform To Treat Age-Related Disease
Read more
Report
Increasing healthy life expectancy: the policy implications of geroscience Royal Society
A policy briefing that explores the emerging field of geroscience, a scientific discipline at the intersection of basic ageing biology, chronic disease and frailty.
Read more
Report
Show more news
How to cite this page
Alion, "SENISCA: key facts", as of Nov 13, 2026. https://alion.io/company/senisca
These figures are published under a free licence. You may reuse them, including commercially, as long as you credit Alion and link back to this page. CC BY-SA 4.0